Patents by Inventor Kevin Henegar

Kevin Henegar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070129550
    Abstract: Certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel are disclosed. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders. Also disclosed are methods of making the ?-amino acids.
    Type: Application
    Filed: December 7, 2006
    Publication date: June 7, 2007
    Applicant: WANER-LAMBERT COMPANY LLC
    Inventors: Peter Blazecka, Joseph Bozelak, Norman Colbry, Timothy Curran, Annise Goodman, Kevin Henegar, Garrett Hoge, Paul Johnson, Augustine Osuma, Mark Plummer, Jacob Schwarz, Derek Vrieze, Ji Zhang
  • Publication number: 20060287309
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: August 24, 2006
    Publication date: December 21, 2006
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu
  • Publication number: 20060287310
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: August 24, 2006
    Publication date: December 21, 2006
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu
  • Publication number: 20060041883
    Abstract: A method for deploying software in a computer system includes providing a deployment maintenance mechanism (DMM) which includes drivers for hardware. A deployment mechanism which includes an image with drivers for hardware and which identifies hardware associated with the computer, along with a native operating system, are also provided. For hardware detected by the deployment mechanism and not having an associated driver in the image, a driver from the DMM is copied into the deployment mechanism using the native operating system. The native operating system is then re-booted to deploy drivers for hardware associated with the computer.
    Type: Application
    Filed: August 19, 2004
    Publication date: February 23, 2006
    Applicant: International Business Machines Corporation
    Inventors: Howell Chambers, Kevin Henegar, David Karner, Andrew Mueller
  • Publication number: 20050197355
    Abstract: Novel compounds are provided having the formula and salts thereof, where R1 is hydrogen, an alkyl, aralkyl, hydroxymethyl, carboxymethyl, acyloxymethyl or trialkylsilyl group, or a group —CH2NR3R4 where N is a linking nitrogen atom and where (a) R3 and R4 are independently selected from hydrogen and alkyl, alkenyl, hydroxyalkyl and alkoxyalkyl groups; (b) R3 is hydrogen or an alkyl, alkenyl, hydroxyalkyl or alkoxyalkyl group, and R4 is —COR5 where R5 is hydrogen or an alkyl, alkenyl, hydroxyalkyl or alkoxyalkyl group; or (c) R3 and R4 taken together with the linking nitrogen atom form a saturated 3- to 7-member heterocyclic group. These compounds are useful intermediates in a process to prepare camptothecin derivatives including the anti-cancer drug irinotecan.
    Type: Application
    Filed: March 2, 2004
    Publication date: September 8, 2005
    Inventor: Kevin Henegar
  • Publication number: 20050187388
    Abstract: The invention provides a method of preparing a compound of formula (I): wherein R, R1, n and m are as defined herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 17, 2005
    Publication date: August 25, 2005
    Inventors: Mateusz Cebula, Kevin Henegar
  • Publication number: 20050187399
    Abstract: The invention comprises an enantioselective method of preparing a compound of formula (IV): wherein n, m, R and R1 are as defined herein. Use of the compounds of formula (IV) in a method of preparing compounds of formula (IX) and novel intermediates useful in the method are also described.
    Type: Application
    Filed: February 17, 2005
    Publication date: August 25, 2005
    Inventors: Mateusz Cebula, Kevin Henegar
  • Publication number: 20050124668
    Abstract: Certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel are disclosed. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
    Type: Application
    Filed: September 24, 2004
    Publication date: June 9, 2005
    Inventors: Christopher Deur, Kevin Henegar, Christine Kolz, Jonathan Miller, Augastine Osuma, Mark Plummer, Brian Samas, Jacob Schwarz, Andrew Thorpe, David Wustrow
  • Publication number: 20050101643
    Abstract: Certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel are disclosed. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders. Also disclosed are methods of making the ?-amino acids.
    Type: Application
    Filed: September 24, 2004
    Publication date: May 12, 2005
    Inventors: Peter Blazecka, Joseph Bozelak, Norman Colbry, Timothy Curran, Annise Goodman, Kevin Henegar, Garrett Hoge, Paul Johnson, Augustine Osuma, Mark Plummer, Jacob Schwarz, Derek Vrieze, Ji Zhang
  • Publication number: 20050043309
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: July 28, 2004
    Publication date: February 24, 2005
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu
  • Publication number: 20050038123
    Abstract: The present invention is a novel intermediate, compound of the formula (VI) and salts thereof. In addition, the invention includes a process for the preparation of a prostaglandin intermediates compounds (IV) and (XVIII) which comprises (1) contacting a the corresponding enone with (?)-chlorodiisopinocampheylborane while maintaining the reaction mixture temperature in the range of from about ?50° to about 0° and (2) contacting the reaction mixture of step (1) with a boron complexing agent.
    Type: Application
    Filed: August 18, 2004
    Publication date: February 17, 2005
    Inventor: Kevin Henegar